Michael Anstey serves as Executive at BICYCLE THERAPEUTICS plc, where they oversee executive responsibilities. Since joining the company, Michael Anstey has executed 4 insider transactions totaling $4.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 28, 2019 involved exercising options for 1,081,823 shares valued at $0.
Michael Anstey currently holds 1,081,823 shares of BICYCLE THERAPEUTICS plc (BCYC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Anstey has been a net buyer of BCYC stock. They have purchased $4.4M and sold $0 worth of shares.
Michael Anstey's most recent insider trade was on May 28, 2019, when they sold 1,081,823 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.00 |
| Discretionary |
| May 28, 2019 | BCYC | $0 | Exercise | 125,587 | $N/A | Discretionary |
| May 28, 2019 | BCYC | $0 | Conversion | 229,741 | $N/A | Discretionary |